Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism

Major bleeding in VTE patients receiving VKA carries a high mortality rate. Intracranial bleeding and renal insufficiency increased the risk. Fresh frozen plasma seems to increase this risk for recurrent VTE.